Crude Heparin Market Growth 2019-2024


Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin. Currently, there are many players in this market. Shenzhen Hepalink, Pharma Action (T?nnies Group), Fengrun Biological, Nanjing King-friend, Hebei Changshan Biochemical and some others are playing important roles in Crude Heparin industry. The market is dispersed for now and is seeing to be more concentrated in the future. There are two different types of Crude Heparin. The market can be segmented into: Pig Intestine Mucosa Heparin, Bovine Heparin and Others. Pig Intestine Mucosa Heparin is almost the only used and efficient types and took 99.6% market share in 2018. By application, LMWH is the largest consumer group, with market share of 89% in 2018. Companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The total competition market for Crude Heparin will become more intense, while the market is going to be more concentrated in the future.

According to this study, over the next five years the Crude Heparin market will register a 15.5% CAGR in terms of revenue, the global market size will reach US$ 4211.2 million by 2024, from US$ 2048.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Crude Heparin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Crude Heparin market by product type, application, key manufacturers and key regions and countries.Download FREE Sample of this Report @

This study considers the Crude Heparin value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7. Pig Intestine Mucosa Heparin Bovine Heparin and Others Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8. UFH LMWH

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Shenzhen Hepalink Pharmaceutical Group Pharma Action (T?nnies Group) Fengrun Biological Technology Nanjing King-friend Biochemical Pharmaceutical Hebei Changshan Biochemical Pharmaceutical Changzhou Qianhong Biopharma Aspen Oss Hepac (Darling Ingredients) Yantai Dongcheng Biochemicals Huaian MDC Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives To study and analyze the global Crude Heparin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024. To understand the structure of Crude Heparin market by identifying its various subsegments. Focuses on the key global Crude Heparin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Crude Heparin with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of Crude Heparin submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies.Get the Complete Report & TOC @

Table of content

2019-2024 Global Crude Heparin Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Crude Heparin Consumption 2014-2024
2.1.2 Crude Heparin Consumption CAGR by Region
2.2 Crude Heparin Segment by Type
2.2.1 Pig Intestine Mucosa Heparin
2.2.2 Bovine Heparin and Others
2.3 Crude Heparin Consumption by Type
2.3.1 Global Crude Heparin Consumption Market Share by Type (2014-2019)
2.3.2 Global Crude Heparin Revenue and Market Share by Type (2014-2019)
2.3.3 Global Crude Heparin Sale Price by Type (2014-2019)
2.4 Crude Heparin Segment by Application
2.4.1 UFH
2.4.2 LMWH
2.5 Crude Heparin Consumption by Application
2.5.1 Global Crude Heparin Consumption Market Share by Application (2014-2019)
2.5.2 Global Crude Heparin Value and Market Share by Application (2014-2019)
2.5.3 Global Crude Heparin Sale Price by Application (2014-2019)

3 Global Crude Heparin by Manufacturers
3.1 Global Crude Heparin Sales Market Share by Manufacturers
3.1.1 Global Crude Heparin Sales by Manufacturers (2017-2019)
3.1.2 Global Crude Heparin Sales Market Share by Manufacturers (2017-2019)

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414

Follow Us On linkedin :


Please enter your comment!
Please enter your name here